Forevia Maxi tablets No. 30

Instructions for Forevia Maxi tablets No. 30

Description

Dietary supplement to the usual diet.

Before use, be sure to read all the information contained in the labeling (on the packaging, in this leaflet).

Composition

1 film-coated tablet contains:

Evening primrose extract (Oenothera biennis L.) 150 mg (mg)

Fennel seed extract (Foeniculum vulgare) 100 mg (mg)

Magnesium (as magnesium oxide) 100 mg (mg)

Chaste tree extract (Vitex agnus castus) 75 mg (mg)

Withania somnifera extract (Withania somnifera) 75 mg (mg)

Ginger extract (Zingiber officinale) 50 mg (mg)

Cimicifuga racemosa extract 25 mg (mg)

Vitamin E 15 mg (mg)

Nicotinic acid 12 mg (mg)

Iron (as iron oxide) 7.5 mg (mg)

Vitamin B6 4 mg (mg)

Vitamin B2 1.3 mg (mg)

Vitamin B1 1.2 mg (mg)

Vitamin D (as cholecalciferol) 10 μg (mcg)

auxiliary components: microcrystalline cellulose, colloidal anhydrous silicon dioxide, starch, croscarmellose sodium, crospovidone, polyvinylpyrrolidone, hypromellose, triacetin, tartrazine, diamond blue, titanium dioxide, talc, magnesium stearate.

GMO-free.

Release form

Film-coated tablets.

Properties

Purpose of use.

Forevia Maxi is a unique complex of phytoextracts, vitamins and minerals that are necessary to support a woman's body during hormonal changes and their consequences:

psycho-emotional manifestations;

decreased libido;

decreased fertility;

tides;

change in body weight;

deterioration of the condition of the skin, hair and bones;

increased need for minerals and vitamins [1, 2].

The advantages of Forevia Maxi include the possibility of an individual approach to a woman, the possibility of comprehensive coverage of several manifestations at the same time, ease of use (one tablet per day), and the possibility of long-term use, which is especially relevant in cases of medical contraindications to hormone therapy. [2]

Endocrinologists note numerous risk factors for hypoestrogenism, which can be divided into:

endogenous, namely:

physiological decrease in ovarian function in women after 40 years of age;

delayed sexual development;

inflammation and cystic transformation of the ovaries in polycystic ovary syndrome;

neoplasms of the endocrine glands (ovaries, adrenal glands, hypothalamus, pituitary gland) or their functional disorders (ovarian insufficiency, adrenal cortex, increased prolactin formation, hypo- or hyperthyroidism);

significant renal failure;

autoimmune disorders (Addison's disease), genetic syndromes (Turner, Prader-Willi, Kallmann), and

exogenous, including:

excessive physical exertion and stress or physical inactivity;

adherence to extreme diets for weight loss and eating disorders (anorexia), the presence of a critical body weight;

use of pharmaceutical drugs (steroids, opioids, psychotropic drugs, inhibitors of estrogen synthesis enzymes used in oncology); surgical interventions on the gonads;

the effects of radiation and chemotherapy [2].

Recommendations for use

It is recommended to consult a doctor before starting use.

The use of Forevia Maxi and its components is appropriate for manifestations of hormonal changes in the following situations:

premenstrual syndrome (PMS);

premenopause;

menopause;

lowering estrogen levels;

excessive discomfort in the reproductive organs [3-11].

The appropriateness of using plant extracts and other components of Forevia Maxi for manifestations of hormonal imbalance at different periods of a woman's life [2]

Reservation

In case of undesirable effects, discontinue use and consult a doctor!

Do not use as a substitute for a complete diet.

Forevia Maxi is not a medicine.

Use during pregnancy and lactation.

Forevia Maxi should not be used during pregnancy and lactation.

Method of application

To maintain hormonal balance: adults take 1 tablet at night after meals or according to an individual regimen as prescribed by a doctor. Duration of use is from 3 to 6 months. Duration of use, if necessary, can be extended.

Children

Forevia Maxi should not be used in children.

Side effect

Individual intolerance to the product components is possible.

Interaction with other tools and other types of interaction

There is a possibility of interaction with dopamine agonists and antagonists, estrogens and antiestrogens due to the presence of Vitex vulgaris extract in the composition.

Overdose

Reactions when exceeding the recommended daily dose are unknown.

Do not exceed the recommended daily intake (serving).

Application features

Do not use if you are hypersensitive to any of the components.

Packaging

30 or 60 film-coated tablets in a jar. 1 jar in a cardboard box with an insert leaflet.

The jar may contain a moisture adsorbent, which is not edible!

Storage conditions

Store in the original packaging at a temperature not exceeding +30 °C in a place protected from light.

Keep out of reach of children.

Do not use after the expiration date.

Producer

Prakruthi Products Pvt. Ltd.

Production address

Bi1/2, Navagadde, Agsur Village, Ankola – 581 314, Karnataka, India.

Importer

LLC "Organosin LTD".

Address

Ukraine, 03022, Kyiv, Academician Knyshova (Amurska) St.,* 6-L.

*previous name of the street – Amurska. Reason for change – Decision of the Kyiv City Council dated 16.12.2021 No. 4026/4067.

The importer performs functions related to accepting claims from consumers.